CX3CR1 Is dispensable for control of mucosal Candida albicans infections in mice and humans

Infection and Immunity

Volumn 83, Issue 3, 2015, Pages 958-965

  Break, Timothy J ^a   Jaeger, Martin ^b   Solis, Norma V ^c   Filler, Scott G ^c,d   Rodriguez, Carlos A ^e   Lim, Jean K ^e   Lee, Chyi Chia Richard ^f   Sobel, Jack D ^g   Netea, Mihai G ^b   Lionakis, Michail S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR4; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 23P19; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; CHEMOKINE RECEPTOR; CX3CR1 PROTEIN, HUMAN; IL17A PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; CANDIDA ALBICANS; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; INFECTION CONTROL; MOUSE; MOUSE MODEL; MOUTH INFECTION; MUCOCUTANEOUS CANDIDIASIS; NONHUMAN; PATHOGEN CLEARANCE; PRIORITY JOURNAL; RECURRENT INFECTION; TONGUE; VAGINA CANDIDIASIS; ANIMAL; C57BL MOUSE; CANDIDIASIS; DEFICIENCY; DISEASE MODEL; GASTROINTESTINAL TRACT; GENE EXPRESSION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; KNOCKOUT MOUSE; MICROBIOLOGY; OPPORTUNISTIC INFECTION; VAGINA;

ALLELES; ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; CANDIDIASIS, VULVOVAGINAL; DISEASE MODELS, ANIMAL; FEMALE; GASTROINTESTINAL TRACT; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERLEUKIN-17; INTERLEUKIN-23; INTERLEUKINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OPPORTUNISTIC INFECTIONS; RECEPTORS, CHEMOKINE; TONGUE; VAGINA;

EID: 84922980802     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02604-14     Document Type: Article

References (49)

1. Vazquez JA, Sobel JD. 2002. Mucosal candidiasis. Infect Dis Clin North Am 16:793-820. http://dx.doi.org/10.1016/S0891-5520(02)00042-9.
2. Fidel PL, Jr, Sobel JD. 1996. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin Microbiol Rev 9:335-348.
3. Smeekens SP, van de Veerdonk FL, Kullberg BJ, Netea MG. 2013. Genetic susceptibility to Candida infections. EMBO Mol Med 5:805-813. http://dx.doi.org/10.1002/emmm.201201678.
4. de Repentigny L, Lewandowski D, Jolicoeur P. 2004. Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin Microbiol Rev 17:729-759. http://dx.doi.org/10.1128/CMR.17.4.729-759.2004.
5. Sobel JD. 1997. Vaginitis. N Engl J Med 337:1896-1903. http://dx.doi.org/10.1056/NEJM199712253372607.
6. Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. 2000. Candida vaginitis: self-reported incidence and associated costs. Sex Transm Dis 27:230-235. http://dx.doi.org/10.1097/00007435-200004000-00009.
7. Marchaim D, Lemanek L, Bheemreddy S, Kaye KS, Sobel JD. 2012. Fluconazole-resistant Candida albicans vulvovaginitis. Obstet Gynecol 120:1407-1414.
8. McDermott DH, Fong AM, Yang Q, Sechler JM, Cupples LA, Merrell MN, Wilson PW, D'Agostino RB, O'Donnell CJ, Patel DD, Murphy PM. 2003. Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J Clin Invest 111:1241-1250. http://dx.doi.org/10.1172/JCI16790.
9. Landsman L, Bar-On L, Zernecke A, Kim KW, Krauthgamer R, Shagdarsuren E, Lira SA, Weissman IL, Weber C, Jung S. 2009. CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 113:963-972. http://dx.doi.org/10.1182/blood-2008-07-170787.
10. Lionakis MS, Swamydas M, Fischer BG, Plantinga TS, Johnson MD, Jaeger M, Green NM, Masedunskas A, Weigert R, Mikelis C, Wan W, Lee CC, Lim JK, Rivollier A, Yang JC, Laird GM, Wheeler RT, Alexander BD, Perfect JR, Gao JL, Kullberg BJ, Netea MG, Murphy PM. 2013. CX3CR1-dependent renal macrophage survival promotes Candida control and host survival. J Clin Invest 123:5035-5051. http://dx.doi.org/10.1172/JCI71307.
11. Lionakis MS. 2012. Genetic susceptibility to fungal infections in humans. Curr Fungal Infect Rep 6:11-22. http://dx.doi.org/10.1007/s12281-011-0076-4.
12. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, Filler SG, Masso-Welch P, Edgerton M, Gaffen SL. 2009. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206:299-311. http://dx.doi.org/10.1084/jem.20081463.
13. De Luca A, Carvalho A, Cunha C, Iannitti RG, Pitzurra L, Giovannini G, Mencacci A, Bartolommei L, Moretti S, Massi-Benedetti C, Fuchs D, De Bernardis F, Puccetti P, Romani L. 2013. IL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis. PLoS Pathog 9:e1003486. http://dx.doi.org/10.1371/journal.ppat.1003486.
14. Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK, Migaud M, Israel L, Chrabieh M, Audry M, Gumbleton M, Toulon A, Bodemer C, El-Baghdadi J, Whitters M, Paradis T, Brooks J, Collins M, Wolfman NM, Al-Muhsen S, Galicchio M, Abel L, Picard C, Casanova JL. 2011. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332:65-68. http://dx.doi.org/10.1126/science.1200439.
15. Gladiator A, Wangler N, Trautwein-Weidner K, LeibundGut-Landmann S. 2013. Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection. J Immunol 190:521-525. http://dx.doi.org/10.4049/jimmunol.1202924.
16. Trautwein-Weidner K, Gladiator A, Nur S, Diethelm P, LeibundGut-Landmann S. 9 July 2014. IL-17-mediated antifungal defense in the oral mucosa is independent of neutrophils. Mucosal Immunol http://dx.doi.org/10.1038/mi.2014.57.
17. Conti HR, Peterson AC, Brane L, Huppler AR, Hernandez-Santos N, Whibley N, Garg AV, Simpson-Abelson MR, Gibson GA, Mamo AJ, Osborne LC, Bishu S, Ghilardi N, Siebenlist U, Watkins SC, Artis D, McGeachy MJ, Gaffen SL. 2014. Oral-resident natural Th17 cells and γδ T cells control opportunistic Candida albicans infections. J Exp Med 211: 2075-2084. http://dx.doi.org/10.1084/jem.20130877.
18. Manta C, Heupel E, Radulovic K, Rossini V, Garbi N, Riedel CU, Niess JH. 2013. CX(3)CR1(+) macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium. Mucosal Immunol 6:177-188. http://dx.doi.org/10.1038/mi.2012.61.
19. Longman RS, Diehl GE, Victorio DA, Huh JR, Galan C, Miraldi ER, Swaminath A, Bonneau R, Scherl EJ, Littman DR. 2014. CX3CR1+ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J Exp Med 211:1571-1583. http://dx.doi.org/10.1084/jem.20140678.
20. Medina-Contreras O, Geem D, Laur O, Williams IR, Lira SA, Nusrat A, Parkos CA, Denning TL. 2011. CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice. J Clin Invest 121:4787-4795. http://dx.doi.org/10.1172/JCI59150.
21. Garcia JA, Pino PA, Mizutani M, Cardona SM, Charo IF, Ransohoff RM, Forsthuber TG, Cardona AE. 2013. Regulation of adaptive immunity by the fractalkine receptor during autoimmune inflammation. J Immunol 191:1063-1072. http://dx.doi.org/10.4049/jimmunol.1300040.
22. Tarrant TK, Liu P, Rampersad RR, Esserman D, Rothlein LR, Timoshchenko RG, McGinnis MW, Fitzhugh DJ, Patel DD, Fong AM. 2012. Decreased Th17 and antigen-specific humoral responses in CX(3)CR1-deficient mice in the collagen-induced arthritis model. Arthritis Rheum 64:1379-1387. http://dx.doi.org/10.1002/art.34320.
23. Combadière C, Potteaux S, Gao JL, Esposito B, Casanova S, Lee EJ, Debre P, Tedgui A, Murphy PM, Mallat Z. 2003. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 107:1009-1016. http://dx.doi.org/10.1161/01.CIR.0000057548.68243.42.
24. National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC.
25. Rahman D, Mistry M, Thavaraj S, Challacombe SJ, Naglik JR. 2007. Murine model of concurrent oral and vaginal Candida albicans colonization to study epithelial host-pathogen interactions. Microbes Infect 9:615-622. http://dx.doi.org/10.1016/j.micinf.2007.01.012.
26. Solis NV, Filler SG. 2012. Mouse model of oropharyngeal candidiasis. Nat Protoc 7:637-642. http://dx.doi.org/10.1038/nprot.2012.011.
27. Koh AY, Kohler JR, Coggshall KT, Van Rooijen N, Pier GB. 2008. Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS Pathog 4:e35. http://dx.doi.org/10.1371/journal.ppat.0040035.
28. Biancotto A, Grivel JC, Iglehart SJ, Vanpouille C, Lisco A, Sieg SF, Debernardo R, Garate K, Rodriguez B, Margolis LB, Lederman MM. 2007. Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood 109:4272-4279. http://dx.doi.org/10.1182/blood-2006-11-055764.
29. Huppler AR, Conti HR, Hernandez-Santos N, Darville T, Biswas PS, Gaffen SL. 2014. Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis. J Immunol 192:1745-1752. http://dx.doi.org/10.4049/jimmunol.1302265.
30. Lionakis MS, Holland SM. 2013. CARD9: at the intersection of mucosal and systemic antifungal immunity. Blood 121:2377-2378. http://dx.doi.org/10.1182/blood-2013-01-480434.
31. Zonios DI, Falloon J, Bennett JE, Shaw PA, Chaitt D, Baseler MW, Adelsberger JW, Metcalf JA, Polis MA, Kovacs SJ, Kovacs JA, Davey RT, Lane HC, Masur H, Sereti I. 2008. Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. Blood 112:287-294. http://dx.doi.org/10.1182/blood-2007-12-127878.
32. Boisson B, Wang C, Pedergnana V, Wu L, Cypowyj S, Rybojad M, Belkadi A, Picard C, Abel L, Fieschi C, Puel A, Li X, Casanova JL. 2013. An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis. Immunity 39:676-686. http://dx.doi.org/10.1016/j.immuni.2013.09.002.
33. Winkelstein JA, Marino MC, Johnston RB, Jr, Boyle J, Curnutte J, Gallin JI, Malech HL, Holland SM, Ochs H, Quie P, Buckley RH, Foster CB, Chanock SJ, Dickler H. 2000. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine 79:155-169.
34. Lehrer RI, Cline MJ. 1969. Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J Clin Invest 48:1478-1488. http://dx.doi.org/10.1172/JCI106114.
35. Martino P, Girmenia C, Venditti M, Micozzi A, Santilli S, Burgio VL, Mandelli F. 1989. Candida colonization and systemic infection in neutropenic patients. A retrospective study. Cancer 64:2030-2034.
36. Glocker EO, Hennigs A, Nabavi M, Schaffer AA, Woellner C, Salzer U, Pfeifer D, Veelken H, Warnatz K, Tahami F, Jamal S, Manguiat A, Rezaei N, Amirzargar AA, Plebani A, Hannesschlager N, Gross O, Ruland J, Grimbacher B. 2009. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 361:1727-1735. http://dx.doi.org/10.1056/NEJMoa0810719.
37. Dejima T, Shibata K, Yamada H, Hara H, Iwakura Y, Naito S, Yoshikai Y. 2011. Protective role of naturally occurring interleukin-17A-producing γδ T cells in the lung at the early stage of systemic candidiasis in mice. Infect Immun 79:4503-4510. http://dx.doi.org/10.1128/IAI.05799-11.
38. Gaffen SL, Hernandez-Santos N, Peterson AC. 2011. IL-17 signaling in host defense against Candida albicans. Immunol Res 50:181-187. http://dx.doi.org/10.1007/s12026-011-8226-x.
39. Farah CS, Hu Y, Riminton S, Ashman RB. 2006. Distinct roles for interleukin-12p40 and tumour necrosis factor in resistance to oral candidiasis defined by gene-targeting. Oral Microbiol Immunol 21:252-255. http://dx.doi.org/10.1111/j.1399-302X.2006.00288.x.
40. Romani L, Mencacci A, Cenci E, Spaccapelo R, Toniatti C, Puccetti P, Bistoni F, Poli V. 1996. Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J Exp Med 183:1345-1355. http://dx.doi.org/10.1084/jem.183.4.1345.
41. Bär E, Whitney PG, Moor K, Reis e Sousa C, LeibundGut-Landmann S. 2014. IL-17 regulates systemic fungal immunity by controlling the functional competence of NK cells. Immunity 40:117-127. http://dx.doi.org/10.1016/j.immuni.2013.12.002.
42. Geissmann F, Jung S, Littman DR. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19:71-82. http://dx.doi.org/10.1016/S1074-7613(03)00174-2.
43. Osterholzer JJ, Chen GH, Olszewski MA, Curtis JL, Huffnagle GB, Toews GB. 2009. Accumulation of CD11b+ lung dendritic cells in response to fungal infection results from the CCR2-mediated recruitment and differentiation of Ly-6Chigh monocytes. J Immunol 183:8044-8053. http://dx.doi.org/10.4049/jimmunol.0902823.
44. Hohl TM, Rivera A, Lipuma L, Gallegos A, Shi C, Mack M, Pamer EG. 2009. Inflammatory monocytes facilitate adaptive CD4 T cell responses during respiratory fungal infection. Cell Host Microbe 6:470-481. http://dx.doi.org/10.1016/j.chom.2009.10.007.
45. Espinosa V, Jhingran A, Dutta O, Kasahara S, Donnelly R, Du P, Rosenfeld J, Leiner I, Chen CC, Ron Y, Hohl TM, Rivera A. 2014. Inflammatory monocytes orchestrate innate antifungal immunity in the lung. PLoS Pathog 10:e1003940. http://dx.doi.org/10.1371/journal.ppat.1003940.
46. Wüthrich M, Ersland K, Sullivan T, Galles K, Klein BS. 2012. Fungi subvert vaccine T cell priming at the respiratory mucosa by preventing chemokine-induced influx of inflammatory monocytes. Immunity 36: 680-692. http://dx.doi.org/10.1016/j.immuni.2012.02.015.
47. Ngo LY, Kasahara S, Kumasaka DK, Knoblaugh SE, Jhingran A, Hohl TM. 2014. Inflammatory monocytes mediate early and organ-specific innate defense during systemic candidiasis. J Infect Dis 209:109-119. http://dx.doi.org/10.1093/infdis/jit413.
48. Pappas PG. 2006. Invasive candidiasis. Infect Dis Clin North Am 20:485-506. http://dx.doi.org/10.1016/j.idc.2006.07.004.
49. Moyes DL, Naglik JR. 2011. Mucosal immunity and Candida albicans infection. Clin Dev Immunol 2011:346307. http://dx.doi.org/10.1155/2011/346307.